Moreover, early depletion of Tregs in vivo by activation of P2RX7-expressing T cells using the NAD+/ART2 axis (known to activate P2RX7 in mouse T cells [53]) in tumor mouse models increased the anti-tumor effector functions of CD8+ T cells [59]. This evidence concerns the gene CD8A and neoplasm.